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Neutropil homogenates contained a high affinity guanosine triphosphatase (GTPase) that was stimulatable 
(+27%) by the addition of 100 nM N-formyl chemotactic peptide (CHO-pep), but not by 1 pg. ml-’ 
phorbolmyristate acetate (PMA). Kinetic analysis of the stimulation demonstrated an apparent lagtime of 
14.3 f 6.9 s between the addition of CHO-pep and the optimal GTPase stimulation. The GTPase activity 
(but not CHO-pep-stimulated GTPase activity) was preserved in a highly purified plasma membrane 
fraction of the homogenate. From these observations we suggest that both a high affinity guanine 
nucleotide binding protein and GTPase are closely associated with the plasma membrane CHO-pep 
receptor. The possibility that GTPase activity may influence guanine nucleotide regulation of adenylate 
cyclase during CHO-pep stimulation of neutrophils is discussed. 
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1. INTRODUCTION 
Human polymorphonuclear leukocytes contain 
a sensory transduction system which initiates 
chemotaxis and microbicidal activity to certain in- 
flammatory stimuli [ 11. Although biochemical 
characterization of the transduction process has 
yet to be elucidated, there is evidence that cyclic 
nucleotides are involved in the stimulation, since 
there is a 2-3-fold transient increase in intracellular 
CAMP which is maximal within 20 s of exposure of 
neutrophils to CHO-peptides [2]. Intracellular 
CAMP elevation does not appear to be a sufficient 
condition for neutrophil activation as dibutyryl 
CAMP is not a stimulus [3], and phorbolesters, 
while fully activating cell function, do not elevate 
intracellular CAMP. However, manipulation of in- 
tracellular CAMP concentration utilizing phos- 
phodiesterase inhibitors or addition of dibutyryl 
CAMP alters the kinetics and magnitude of cellular 
response to ligand [3]. 
(NJ guanine triphosphate-binding proteins [4,5]. 
Termination of the hormone-mediated regulatory 
capacity of Ni and N, may occur by hydrolysis of 
bound GTP, by a specific high affinity GTPase 
[5-91. The locus of the GTPase activity (with 
respect to Ni and NJ and its regulation during 
hormone-dependent guanine nucleotide modula- 
tion of cyclase activity remains unknown. 
In the human neutrophil, the CAMP system may 
involve N-binding proteins, since it was reported 
[lo] that the non-hydrolysable analogue of GTP 
(GppNHp) reduced the affinity of the formyl pep- 
tide receptor for CHO-pep by increasing the 
dissociation rate constant. Furthermore, authors 
in [Ill reported that purified neutrophil plasma 
membrane adenylate cyclase activity was activated 
by incubation with guanine nucleotides. 
Hormonal regulation of adenylyl cyclase activity 
is mediated by both inhibitory (Ni) and stimulatory 
Here we demonstrate that homogenates from 
human neutrophils contain a CHO-peptide- 
activatable GTPase. From the kinetics of this ac- 
tivation, we speculate that GTPase activation is in- 
volved in the termination sequence of cyclase ac- 
tivation by CHO-peptide-NS complex. 
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2. MATERIALS AND METHODS 
2.1. Preparation of cells 
Human neutrophils were prepared from freshly 
drawn venous blood as in [12]; 120-250 ml blood 
yielded between 0.2-l x 10’ cells of greater than 
95% purity. Cells were suspended at a concentra- 
tion of 10’ ml-’ in a buffer containing 5 mM KCl, 
147 mM NaCl, 1.9 mM KHzP04, 1.1 mM 
KzHPOd; 5.5 mM glucose, 1.5 mM CaC12,0.3 mM 
Mg SO4 and 1 mM MgClz (pH 7.4) at room 
temperature. 
fluoresceinated hexapeptide (FLPEP) [ 151. PMA 
was from Sigma. The peptide and PMA were 
stored at stock solutions at - 20°C in DMSO. Ali- 
quots were added to Gey’s physiologic buffer (pH 
7.4) containing 0.1% bovine serum albumin (BSA) 
such that the peptide concentration was 3.4 x 10m6 
M and PMA was 68 x 10e3 g/l. The final concen- 
tration of DMSO in the GTPase assay was 0.9 
pl.rnl-‘, and an aliquot of Gey’s-BSA buffer con- 
taining DMSO was added to control assay systems 
for GTPase activity in the absence of peptide or 
PMA. 
2.2. Neutrophil protease inhibition 2.6. Measurement of levels of CAMP in human 
The cell suspension was treated with 0.5 
ml.ml-’ diisopropylfluorophosphate (DFP, 
Sigma, St. Louis, MO) for 5 min with occasional 
agitation. The cells were then sedimented at 1000 
x g for 5 min. This procedure abolishes all serine 
protease activity [ 131. 
neutrophils 
2.3. Homogenization by nitrogen cavitation 
The cell pellet was then rapidly dispersed at 2.5 
x lo7 cells. ml-’ in a homogenizing buffer con- 
taining 50 mM imidazole-HCl, 3 mM MgC12, 0.5 
mM EGTA, 5% Ficoll400 (Parmacia, Uppsala), 2 
mM mercaptoethanol (pH 6.7) at 37°C. The cell 
suspension was placed in a 50-ml polyethylene tube 
with a cylindrical stir bar in a pre-cooled Parr cell 
disruption bomb (Parr Instruments, Moline, IL). 
The stirred cell mixture was equilibrated for 10 min 
at 400 lb/in2 N2 at 0°C and then lysed. The foamy 
layer was gently dispersed in a glass homogenizer. 
Ninety percent of the starting volume was 
recovered, and microscopic examination of the 
lysate revealed no intact cells. The homogenate 
was utilized in GTPase assays without further 
purification. 
CAMP levels in stimulated cells were measured 
with the RIA kit from NEN (Boston, MA). Cells 
(5 x lo6 ml-‘) were equilibrated for 7 min at 37°C 
prior to stimulation with 10 nM FLPEP. After 
stimulation, aliquots of the cell suspension were 
withdrawn at timed intervals and transferred to a 
glass test tube heated to 150°C in a bath of 
ballotini beads (Atlas Chemical, San Diego, CA). 
The sample boiled within 2 s, inhibiting further 
alteration of the CAMP levels. The analysis from 
this point on essentially followed that in [16]. 
2.7. GTPase assay 
2.4. Preparation of plasma membranes 
Purified plasma membranes were prepared from 
DFP-treated cells as in [14], and suspended in 50 
mM imidazole-HCl, 2 mM ,&mercaptoethanol, 3 
mM MgClz, 0.1 mM EGTA, 5% Ficoll 400 (pH 
7.4) at 4°C at a protein concentration of 1 
mg.ml-‘. 
The assay conditions were similar to those in [6]. 
The assay media contained 0.5 PM [T-~~P]GTP 
(15-20 mCi/hmol, New England Nuclear, MA), 5 
mM MgClz, 0.8 mM App(NH)p (Sigma), 4 mM 
creatine phosphate (Sigma), 51 units of creatine 
phosphokinase (Sigma), 2 mM&mercaptoethanol, 
0.1 mM EGTA, 50 mM imidazole-HCl (pH 6.7) at 
37°C; 850~1 of this assay medium were transferred 
into a water jacketed 3 ml stirred plastic chamber 
at 37°C. To this was added 50~1 of a solution con- 
taining CHO-peptide (final concentration 100 nM) 
or an identical solution but in the absence of pep- 
tide. The assay was initiated by the addition of 
either an 800 ~1 aliquot of cell homogenate or 
plasma. In studies with PMA, a 25 ~1 aliquot of the 
drug was added to both the pre-equilibrating 
homogenate and to the assay media 60 s before in- 
itiation of the assay. 
2.5. Preparation of CHO-peptide and PMA 
solutions 
The peptide utilized here was the derivatized 
At lo- or 15-s intervals following the initiation 
of the assay, 100 ~1 aliquots were removed from 
the stirring chamber and immediately mixed with 
0.1 ml 2.5% SDS (with stirring to terminate the 
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GTP hydrolysis). The aliquots were frozen on dry 
ice for 16 h. The extent of GTP hydrolysis in the 
thawed samples was determined as in [6], utilizing 
charcoal columns to adsorb nucleotides from each 
reaction mixture. Hydrolysed phosphate eluates 
were collected and analyzed for “P in a Searle li- 
quid scintillation spectrometer with wide open 
counting windows. Background 32P contaminating 
the [y-32P]GTP was subtracted from all values and 
usually fell in the range of 3-8% of total 32P. 
3. RESULTS 
A representative plot of the time course of GTP 
hydrolysis in the presence and absence of the 
derivatized hexapeptide is shown in fig. 1. A clear 
activation of GTP hydrolysis is observed in the 
presence of peptide. In table 1 are summarized the 
data from 4 separate experiments utilizing cells 
from 4 different donors. Since the mean regression 
coefficients from activity plots plus and minus 
peptide were both very close to + 1, and were not 
significantly different from one another, it can be 
concluded that the presence of the peptide produc- 
ed a sustained simulation of GTPase activity of 
about 27% over the time course of the experiment. 
Furthermore, an apparent lag time for peptide 
stimulation of GTPase activity can be calculated 
from the extrapolated intersection of the activities 
in each set of data (table l), yielding mean lag time 
, 
Frg. 1. Kinetics of 0.25 PM GTP hydrolysis in the 
presence (0) and absence (0) of 100 nM chemotactic 
hexapeptide byhuman eutrophil homogenates at 37°C. 
of activation of 14.3 + 6.9 s. The addition of 
PMA (1 pg. ml-‘) to the homogenates 1min prior 
to the imtiation of the assay did not alter GTPase 
activity (table 1). In separatr studies, we found 
that a PMA concentration oi _ pg. ml-’ fully ac- 
tivated superoxide production after a lag time of 
about 60 s. 
The GTPase activity in purified plasma mem- 
branes is shown in fig. 2. Since GTP hydrolysis is 
observed in the presence of 0.25 PM GTP it can be 
Table 1 
Activities of neutrophil homogenate GTPase incubated with or without chemotactic hexapeptide (100 nM) or phorbol 
myristate acetate (1 pg. ml-‘) at 37°C 
Assay number 1 2 3 4 Mean k SD 
Peptide 
- + - + - + - + - + 
Activity 
(pm01 Pi. min-’ . lo6 cells-‘) 0.377 0.496 0.416 0.476 0.424 0.510 0.391 0.564 0.402k 0.512k 
0.019 0.032 
(Stimulation = 27%) 
Regression coefficient 0.989 0.989 0.998 0.997 0.997 0.997 0.995 0.989 0.995 zk 0.0993 f
0.035 0.004 
P=NS 
Lag time (s) 12 5 16 24 14.3 f 6.9 
No additions + PMA + Peptide 
Activity 
(pm01 Pi f min-’ . lo6 cells-‘) 0.302 0.299 0.378 
Regression coefficient 0.997 0.999 0.995 
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Fig. 2. Kinetics of 0.25 PM GTP hydrolysis by purified 
plasma membranes from human neutrophils at 37°C. 
concluded that there is a low K,,, GTPase activity 
in neutrophil plasma membranes, with a specific 
activity comparable with other cell types with hor- 
mone stimulatable GTPases [6,9,17]. 
No stimulation of this activity was apparent 
when the purified membranes were incubated with 
derivatized hexapeptide (not shown), indicating 
that the stimulatable activity may not be stable 
during subfractionation. 
Finally, in order to compare CAMP accumula- 
tion and GTPase activation by CHO-pep the 
kinetics of intracellular CAMP activation were ex- 
amined in experiments parallel to those in table 1. 
The results of this study are shown in fig. 3. In- 
tracellular CAMP reached a maximum after about 
10 s, and gradually declined toward basal values 
after about 2 min. These kinetics are very represen- 
tative of steady-state intracellular levels on ex- 
posure to the peptide reported in [3] and [2]. 
Fig. 3. Time course of intracellular CAMP concentration 
after exposure of intact human neutrophils to 100 nM 
chemotactic peptide at 37°C. 
4. DISCUSSION 
The neutrophil homogenates contain a high af- 
finity GTPase which is stimulatable (+27%) by 
the addition of the chemotactic hexapeptide. The 
highly purified plasma membrane GTPase activity 
did not respond to the presence of CHO-peptide 
utilizing the subfractionation procedure in [ 141. 
Unfortunately we cannot yet localize the 
stimulatable GTPase activity to the plasma mem- 
brane at this stage. Since the CHO-peptide leads to 
a rapid and transient elevation in the intracellular 
levels of CAMP, it is reasonable to assume that this 
is achieved, at least in part, by activation of the 
cyclase system, rather than solely by inhibition of 
phosphodiesterase activity. This notion is sup- 
ported by the idea that, if anything, the transient 
elevation of intracellular Ca2+ following 
neutrophil activation is expected to increase PDE 
activity [ 181. 
High affinity N-binding proteins have been sug- 
gested to be intimately associated with the N- 
formyl peptide as well as other receptors, since 
Gpp(NH)p-binding increases the peptide off-rate 
from its receptor [9]. If the N-formyl-peptide- 
adenylate cyclase system in human neutrophils is 
analogous to the myriad of other hormone 
stimulation adenylate cyclase systems, then the 
high affinity GTPase activity observed in this 
study within the neutrophil plasma membrane 
matrix could possibly serve as the terminating 
signal for modulation of cyclase activity by N- 
binding proteins. 
The time course of GTPase activation by CHO- 
peptide is consistent with its role in cyclase 
modulation. The GTPase activation appears to 
persist after CAMP elevation following peptide ad- 
dition to neutrophils. Thus, this GTPase activation 
would compete against the cyclase activation se- 
quence and serve to modulate the rise in CAMP. 
PMA is a powerful activator of neutrophil granule 
release [2] and the respiratory burst [19]. This 
agent, however, does not elicit a rise in neutrophil 
intracellular CAMP [2], and is unable to alter 
neutrophil homogenate GPTase activity (table 1) 
after preincubation of the homogenate with 1 
pg. ml-’ PMA for 60 s. We suggest that this obser- 
vation is consistent with the view that GTPase ac- 
tivation occurs by ligand-specific receptor interac- 
tion, and is not secondary to neutrophil activation. 
168 
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Finally, while the statistical analysis of the GTPase 
activation is consistent with a sustained activation 
preceded by a lag period, the high basal activity 
precludes an absolute conclusive discrimination 
between sustained and transient GTPase activa- 
tion. A more thorough analysis awaits a purified 
membrane preparation possessing an activatable 
GTPase, 
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